Vertex Pharmaceuticals Incorporated (VX1)
Market Closed
24 Feb, 20:00
€
412. 95
+2.8
+0.68%
€
- Market Cap
30.83 P/E Ratio
- Div Yield
109 Volume
14.94 Eps
€ 410.15
Previous Close Day Range
405.85 414.4
Year Range
312.65 478.1
Want to track VX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
VX1 earnings report is expected in 69 days (4 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 3.76 | - |
| | | 4.41 | - |
| | | 5.15 | - |
| | | 5.14 | - |
| | | 4.58 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
VX1 Earnings Reports FAQ
What is the earnings per share (EPS) for VX1?
The current EPS is 14.94.
What is the company's earnings growth rate?
Vertex Pharmaceuticals Incorporated has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-04, based on the VX1's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Vertex Pharmaceuticals Incorporated are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for VX1 at this time, as Vertex Pharmaceuticals Incorporated has no recent EPS data to calculate it.
